DE VERNEUIL VANINA (EVP, General Counsel, Corp Sec) sold 3.3% of their position (4.45K shares) of VIR BIOTECHNOLOGY, INC. on the open market
Open‑market sale worth $33.1K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/24/2026ACC: 0001628280-26-011328
Officer· EVP, General Counsel, Corp Sec
Since Feb 2026
+160.56K
Net shares
Net buyer
$33.1K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
165K acquired · 4.45K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+55K
Price / share
—
Trade value
—
% of position
69.4%
2/22/2026
79.24K→134.24K
Common Stock
Direct
Shares
−4.45K
Price / share
$7.45
Trade value
$33.13K
% of position
3.3%
2/23/2026
134.24K→129.80K
Total
Net shares
+50.55K
Net value
-$33.13K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/22/2026 | A · Award | +55K | — | — | 69.4% | 79.24K | 134.24K |
| Common Stock Direct | 2/23/2026 | S · Sale | −4.45K | $7.45 | $33.13K | 3.3% | 134.24K | 129.80K |
| Total | +50.55K | -$33.13K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
110K shares
Shares
+110K
Strike price
7.56
Held after
110K
Exercisable
—
2/22/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock110K shares | 2/22/2026 | A · Award | +110K | 7.56 | — | 110K |